On May 31, 2023 Promontory Therapeutics Inc., a clinical stage pharmaceutical company advancing small molecule immunotherapies in oncology, reported that it will participate in a panel discussion on maximizing value in a capital efficient manner at the Sachs 9th Annual Immuno-Oncology Innovation Forum, taking place June 2, 2023 in Chicago (Press release, Promontory Therapeutics, MAY 31, 2023, View Source [SID1234632285]). The company will also provide a presentation on its corporate and clinical progress with lead therapeutic candidate, PT-112, a small molecule immunotherapy.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Panel Discussion Details
Panel Session: Business Development Strategies Panel: How to Maximize Value in a Capital Efficient Manner
Speaker: Matthew Price, EVP & COO, Promontory Therapeutics
Date: June 2, 2023
Time: 9:30am CDT
Location: Sinclair Ballroom, Waldorf Astoria Hotel, Chicago

Corporate Presentation Details
Presentation Session: Track A
Speaker: Johan Baeck, CMO, Promontory Therapeutics
Date: June 2, 2023
Time: 11:00am CDT
Location: Room Faulkner, Waldorf Astoria Hotel, Chicago

More information about the event and agenda is available on the Sachs Forum website.